
GC19228
LXH254
Also known as N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-yl-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide
LXH254 is a potent CRAF inhibitor extracted from patent WO2018051306A1, Compound A
ChemicalCAS1800398-38-2MW502.49FormulaC25H25F3N4O4
- CAS number
- 1800398-38-2
- Molecular weight
- 502.49
- Formula
- C25H25F3N4O4
- Solubility
- DMSO : ≥ 83·3 mg/mL (165·77 mM)
- InChIKey
- UEPXBTCUIIGYCY-UHFFFAOYSA-N
- Catalogue number
- GC19228
- Brand
- GLPBIO
Computed properties PubChem CID 90456533 · XLogP 3.2 · TPSA 96.8 Ų · H-bond donors 2
- XLogP
- 3.2
- TPSA
- 96.8 Ų
- H-bond donors
- 2
- H-bond acceptors
- 10
- Rotatable bonds
- 7
- Heavy atoms
- 36
SMILES CC1=C(C=C(C=C1)NC(=O)C2=CC(=NC=C2)C(F)(F)F)C3=CC(=NC(=C3)OCCO)N4CCOCC4
Computed descriptors from PubChem (CID 90456533), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il